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IntroductIon
Studies have shown that variations in genes that encode enzymes 
involved in carbohydrate metabolism pathways are associated 
with an increased risk of obesity and related traits (1–4). One 
such gene, which may be involved in the pathogenesis of  obesity, 
is the phosphoenolpyruvate carboxykinase-1 (PCK1, also 
known as PEPCK1) gene, as it encodes the cytosolic isozyme 
of phosphoenolpyruvate carboxykinase (5). A recent study 
showed an association between human PCK1 mRNA expres-
sion in subcutaneous adipose tissue and BMI (6). Besides func-
tioning as a gluconeogenic enzyme catalyzing the conversion 
of oxaloacetate to phosphoenolpyruvate in the liver and kidney 
(7), PCK1 is also a target for peroxisome proliferator- activated 
receptor-γ co-activator 1α (PPARGC1A) (8), a  mediator of 
 adipocyte  differentiation and metabolism (9).
Animal studies involving whole body and tissue-specific 
Pck1 knockout mice and tissue-specific overexpression of PCK1 
have resulted in obesity, lipodystrophy, and fatty liver (10). 
Overexpression of Pck1 was found to result in obesity as a result 
of increased glyceroneogenesis and fatty acid esterification (11). 
Transgenic rats overexpressing the Pck1 gene and lacking its 
entire upstream regulatory region were found to develop mild 
glucose intolerance, hyperinsulinemia and were prone to weight 
gain (12). This effect was further supported by another study, 
where Pck1 overexpression in adipose tissue of mice in the pres-
ence of high-fat feeding resulted in low levels of energy expendi-
ture, obesity, severe insulin resistance, and type 2 diabetes (13). 
Recently, it was shown that increased expression of the Pck1 gene 
in transgenic mice leads to enhanced capacity to imposed  exercise 
with an increase in the number of mitochondria and content of 
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triglyceride in the skeletal muscle (14). This is  consistent with 
the evidence for the paradox in endurance-trained athletes, 
where skeletal muscle of trained endurance athletes is markedly 
insulin sensitive and has a high oxidative capacity, despite hav-
ing elevated lipid content (15). Moreover, transgenic mice ate 
60% more but had half the body weight and 10% of the body 
fat compared to the control mice (14). Thus, it would seem that 
PCK1 enhances the storing of energy as fat, which in the pres-
ence of positive energy balance or perhaps specifically inactivity 
is detrimental for health but in the presence of physical activity 
(PA) leads to enhanced exercise capacity.
Regions near the PCK1 locus on human chromosome 20 have 
been implicated in obesity (16). In addition, several studies in 
humans have shown associations of specific polymorphsims in 
the PCK1 gene with type 2 diabetes and related metabolic traits 
(4,17–20). However, the present study investigates the associa-
tion of single-nucleotide polymorphisms (SNPs) in the PCK1 
gene with obesity, PA, and fitness and examines the interaction 
between the PCK1 SNPs, and PA and fitness on obesity risk in 
the European Youth Heart Study (EYHS), a large population-
based study of children and adolescents from Denmark and 
Estonia.
Methods and Procedures
study population
The details of the EYHS have been described in detail previously 
(21–23). In brief, the EYHS is a school-based, cross-sectional study of 
pre- and early pubertal children randomly selected by a two-stage sam-
pling strategy conducted in four countries: Denmark, Estonia, Norway, 
and Portugal. Genotypic data are available in two of the EYHS study 
centers (Denmark and Estonia). A total of 958 boys and 1,104 girls 
from Denmark and Estonia were included in the analyses (Table 1). 
These boys and girls were recruited into two age-groups: children 
(school grade 3) (mean ± s.d. age: 9.6 ± 0.4 years; range: 8.4–11.3 years) 
and adolescents (school grade 9) (mean age: 15.5 ± 0.5 years; range: 
14.1–17.8 years). The study was approved by the local research ethics 
committees of each study center and performed in accordance with the 
Helsinki Declaration. All parents gave written informed consent for 
their child to participate and all children gave verbal assent.
Measurements
Weight and height were measured using standard techniques with the 
participants in light clothing and barefoot. BMI was calculated as weight 
(kg)/height (m2). BMI was standardized according to BMI reference 
charts derived by the Cole et al. LMS method (24). Waist  circumference 
(WC) in centimeters was measured with a metal  anthropometric tape 
midway between the lower rib margin and the iliac crest, at the end of 
gentle expiration. The measurements were taken twice, and the mean of 
the two values was used for further calculations. Four skinfold thickness 
measurements (triceps, biceps, subscapula, and suprailiac; mm) were 
taken on the left side of the body in duplicate or triplicate, according to 
the criteria described by Lohman et al. (25), and the two closest measure-
ments at each site were averaged. The sum of skinfolds has been shown 
to correlate highly with dual-energy X-ray  absorptiometry–measured 
percentage body fat (26). Both inter- and intratester reliability data 
were recorded for skinfold and waist/hip circumference measurements 
where the skill of the tester might influence the results. The data sug-
gested that both inter- and intratester variability are within acceptable 
limits and that it is unlikely that significant between-country testing 
errors have been introduced (21). Sexual maturity was assessed using 
the five-stage scale for breast development in girls and pubic hair in 
boys, according to Tanner (27).
PA was assessed with an MTI ActiGraph (Manufacturing  Technology, 
Fort Walton Beach, FL) accelerometer over two weekdays and two 
weekend days (28–30). The outcome variable was daily activity (counts/
min) that is an indicator of the total amount (average intensity) of PA. 
This variable was derived by dividing total accelerometer counts/day 
by the duration the accelerometer was worn on each day, and then 
averaging across the measurement days. This variable has been shown 
to be significantly correlated with PA energy expenditure obtained by 
the doubly labeled water method (31). In addition, fraction of time 
spent sedentary (<500 counts/min) and at moderate-to-vigorous inten-
sity physical activity (MVPA, >2,000 counts/min) were derived. Our 
threshold for MVPA corresponds to a walking speed of ~3–4 km/h (30). 
Before analyses, we excluded all time blocks with ten or more consecu-
tive minutes of zero counts, assuming that the monitor was not worn 
during that time. On this basis, we included all individuals accumulat-
ing at least 600 min/day for at least 3 days including one weekend day. 
Accelerometric PA data were available for 1,294 children. In addition 
to the objective measures of PA, inactivity was assessed subjectively 
by number of hours/week spent on TV viewing. Sleep time was not 
included in the period of inactivity.
Physical fitness was determined by a maximum cycle ergometer test, 
as previously described (32). Briefly, the workload was preprogrammed 
to increase on a computerized cycle ergometer (Monark 839 Ergomedic 
Monark Exercise, Varberg, Sweden) every third minute until exhaustion. 
Initial workload and increments were 20 or 25 W, depending on whether 
the body mass of the child was below or above 30 kg. Heart rate was 
registered continuously (Polar Vantage NV; Polar Electro Oy, Kempele, 
Finland). Criteria for exhaustion were a heart rate >185 beats/min, failure 
to maintain a pedaling frequency of at least 30 rpm, and a subjective judg-
ment by the observer that the child could no longer keep up, even after 
vocal encouragement. All children from one country were tested by the 
same person. The maximal power output (Wmax) was calculated as the 
power in the last fully completed workload plus the power increment of 
table 1 Participant characteristics by gender and age-group in the european Youth heart study
Phenotypes
Boys (n = 958) Girls (n = 1,104)
Children (n = 586) Adolescents (n = 372) Children (n = 638) Adolescents (n = 466)
Age (years) 9.7 ± 0.4 15.5 ± 0.5 9.6 ± 0.4 15.5 ± 0.5
BMI (kg/m2)a 0.25 ± 1.0 0.22 ± 0.92 −0.006 ± 1.1 0.01 ± 0.96
BMI (kg/m2)b 17.11 ± 2.2 20.5 ± 2.55 17.08 ± 2.6 20.57 ± 2.7
Waist circumference (cm) 59.1 ± 1.8 71.1 ± 5.6 58.0 ± 6.3 66.6 ± 5.5
Sum of four skinfolds (mm) 29.91 ± 11.6 29.9 ± 12.9 33.6 ± 15.8 45.2 ± 16.3
Physical activity (counts/min) 745.6 ± 11.6 (n = 406)c 550.3 ± 17.9 (n = 175)c 615.7 ± 8.9 (n = 446)c 452.7 ± 10.1 (n = 267)c
Values are represented as mean ± s.d.
aBMI standardized according to BMI reference charts derived by Cole’s least median squares method (22). bUncorrected BMI values. cNumber of samples for which the 
accelerometric physical activity data are available.
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the last step multiplied by the time proportion completed of the last step. 
Wmax was expressed as W/kg body weight (i.e., normalized as a ratio).
snP genotyping
In order to capture most of the common genetic variations in the PCK1 
gene, we selected seven tag-SNPs using data from the CEU popula-
tion of the International HapMap project, phase II (HapMap release 
19, dbSNP 125). Tag-SNPs were selected using the pairwise correlation 
between markers (r2 >0.8; minor allele frequency (MAF) ≥5%) (http://
www.broad.mit.edu/mpg/tagger/), as implemented in Haploview v4.0 
(http://www.broad.mit.edu/mpg/haploview). In addition, we selected 
one frequently studied SNP (rs28359554) from the literature, amount-
ing to a total of eight SNPs. Of these eight SNPs, one (rs1042521) was 
excluded from analyses because it did not meet the Hardy–Weinberg 
equilibrium expectations (P = 0.02). Thus, we analyzed 7 SNPs (6 from 
HapMap and 1 from literature). Although the seven tag-SNPs captured 
all common (MAF >5%) variation reported by the HapMap release 19, 
they capture 50% of the common SNPs (MAF >5%) reported in the 
current HapMap release 26. Genotyping of the PCK1 gene SNPs was 
performed by Illumina (San Diego, CA) using the Illumina BeadStation 
custom array (Illumina). The overall call rate for the Illumina genotyp-
ing was >98%. The minor allele frequencies of the SNPs ranged from 
0.07 to 0.50 (Supplementary Table S1 online). Pairwise correlations 
between SNPs ranged from r2 = 0.01–0.68 (Figure 1).
statistical analysis
Statistical analyses were conducted using SAS 9.1 for Windows (SAS 
Institute, Cary, NC). A likelihood ratio test was performed to confirm 
that the observed genotype distributions were in Hardy–Weinberg 
equilibrium (P > 0.01) (Supplementary Table S1 online). The genotype 
distribution of six SNPs for Danish and Estonian children were signifi-
cantly different (P < 0.05), and therefore, we adjusted for  country in the 
association analyses and also examined whether the  associations were 
different between Estonians and Danish by testing a SNP ×  country 
interaction term. The associations between the SNP and BMI, and SNP 
and PA were tested using generalized linear models assuming an addi-
tive effect for each additional minor allele. Interactions between SNP 
and age-group, gender, or country were also tested by including the 
respective interaction terms in the model. All models were adjusted 
for age, age-group, gender, sexual maturity, and country. In addition 
to the variables mentioned, the association of the SNPs with WC and 
sum of four skinfolds was adjusted for height, and the association of 
the SNPs with fitness was adjusted for body weight. Obesity (n = 107) 
and overweight (n = 312) were defined as BMI above the 95th and 85th 
percentiles, respectively, for European children (33). WC and the sum 
of four skinfolds were log-transformed to obtain normal distribution 
for analyses; thus, geometric means are reported in the tables.
Haplotype analyses were carried out for seven-marker haplotypes. 
Haplotypes prevalent at >5% were retained for further haplotype analy-
ses. Haplotype trend regression analysis was performed to test for associa-
tion between common haplotypes and BMI. Haplotype analysis was done 
using “R” statistical software (version 2.9.2; http://www.r-project.org).
Power calculation
We calculated the power of the present study to detect effect sizes for 
BMI (β = 0.05–0.35 kg/m2 per minor allele), PA (β = 10–70 counts/min 
per minor allele), and fitness (β = 2–16 watts per minor allele) for a 
range of minor allele frequencies (0.05–0.50) using the Quanto v1.1.1 
(http://hydra.usc.edu/gxe) for a sample size of 2,062 individuals for BMI 
and 1,294 individuals for PA (Supplementary Figures S1–S3 online).
results
We investigated the association of the seven SNPs in the PCK1 
gene with obesity-related phenotypes such as BMI, WC and 
sum of four skinfolds and found that none of the SNPs were 
associated with any of the obesity-related traits (Table 2). 
Accordingly, we found no association between these SNPs and 
the risk of being overweight or obese (P > 0.05). In addition, 
we did not find any evidence of gender-specific effects (P > 
0.05), age-group-specific effects (P > 0.05) or country-specific 
effects (P > 0.05).
We also looked at the association of the PCK1 gene SNPs with 
PA, fraction of time spent at MVPA and fitness and found that 
the SNPs failed to show any association (Table 3). We exam-
ined the interaction between the SNPs, and the PA and fitness 
in our study population and found that none of the interac-
tions between the SNPs and PA on obesity traits were statisti-
cally significant (P > 0.05). None of the haplotypes showed an 
association with BMI (Supplementary Table S2 online).
dIscussIon
In the present study, we examined the association of the seven 
variants in the PCK1 gene with obesity-related phenotypes 
such as BMI, WC and sum of four skinfolds in a cross- sectional 
study of pre- and early pubertal children from Denmark and 
Estonia. None of the variants were associated with any of the 
obesity-related traits. Despite strong evidence from animal 
studies (11–13), we could not find any evidence for the asso-
ciation of PCK1 variants with obesity-related phenotypes in 
children and adolescents. Previous studies have shown asso-
ciation between genetic variation in PCK1 and the risk of type 
2 diabetes and related traits (4,17–20), of which we genotyped 
four (rs6070157, rs2179706, rs1042531, and rs707555) but 
found no evidence for association in the EYHS. As this is the 
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first study examining the association of genetic variants in 
PCK1 gene with obesity in young individuals, more studies are 
needed to explore the association of PCK1 gene variants with 
obesity-related phenotypes in other populations.
A recent study showed that increased expression of Pck1 gene 
in transgenic mice leads to a high level of PA with an increase 
in the number of mitochondria, larger triglyceride reserves in 
their skeletal muscle and enhanced food intake (14). Therefore, 
to test the hypothesis that variations in the PCK1 gene are asso-
ciated with levels of PA, we examined the association of the 
PCK1 SNPs with PA and the fraction of time spent at MVPA 
and found that none of the SNPs showed an association. We 
also looked at the association of the PCK1 gene SNPs with fit-
ness and found that the SNPs failed to show any association. 
In another study, physical exercise reduced hepatic Pck1 gene 
expression to ameliorate the insulin resistance in obese Zucker 
rats and also to improve insulin sensitivity in lean animals 
(34). Given the role of PCK1 in contributing to PA in animals, 
we hypothesized that living a physically active lifestyle would 
overcome the predisposition to obesity conveyed by PCK1 gene 
polymorphisms, despite the fact that the SNPs are not associ-
ated with obesity in humans. The reason we pursued this pos-
sibility is that gene × environment interactions might conceal 
a main effect of the environment or genetic polymorphisms on 
obesity risk. Therefore, we looked at the interaction between 
the SNPs and the PA and fitness in our study population. We 
found that none of the interactions between the SNPs and PA 
on obesity traits were statistically significant.
Although the results are negative, the findings are of 
 relevance, as it is the first study to examine the association 
of PCK1 SNPs with obesity and PA. Importantly, as shown 
in the Supplementary Figures S1–S3 online, our study was 
sufficiently powered to test these hypotheses. Thus, a negative 
finding is unlikely to be owing to type 2 error. One strength of 
this study is that we examined the effect of the SNPs on obes-
ity and PA during the early stages of life, when environmen-
tal and behavioral factors have had less time to substantially 
modify the phenotype and therefore, this study on children 
and  adolescents gains importance.
In this study, we failed to show an association of PCK1 gene 
SNPs with obesity, PA or fitness, which may be due to the 
following reasons. We found that, with our sample size, we 
had 80% power to identify effect sizes for BMI >0.2 kg/ m2 per 
minor allele, PA >60 counts/min per minor allele (approxi-
mately equivalent to 10–15 min of brisk walking) and  physical 
fitness >11 watts per minor allele at the significance level of 
0.05 (Supplementary Figures S1 and S2 online). If the true 
effect sizes are lower, we would not be able to detect them. 
table 2 results for association tests between PCK1 polymorphisms and obesity-related traits
Polymorphisms Genotypes
N (BMI, WC, 
sum of four 
skinfolds)
Standardized BMI (kg/m2) Waist circumference (cm) Sum of four skinfolds (mm)
Mean s.e. P valuea Mean s.e. P valueb Mean s.e. P valueb
rs1328756 
(−1096T/C)
CC 355 0.09 0.05
0.85
62.62 0.29
0.48
33.31 0.66
0.62CT 1,027 0.12 0.03 62.39 0.17 33.04 0.39
TT 668 0.11 0.04 62.34 0.21 32.89 0.48
rs6070157 
(Ile94Ile)
TT 118 0.11 0.09
0.61
62.11 0.51
0.89
34.25 1.18
0.71TC 801 0.13 0.03 62.47 0.19 32.84 0.43
CC 1,130 0.10 0.03 62.39 0.16 33.05 0.37
rs707555 
(Leu184Val)
GG 1,536 0.11 0.02
0.92
62.44 0.14
0.79
33.0 0.31
0.92GC 473 0.11 0.04 62.41 0.25 33.27 0.57
CC 39 0.14 0.15 62.13 0.88 32.07 1.92
rs2070755  
(IVS 4 + 85C/G)
GG 482 0.05 0.04
0.26
62.39 0.25
0.89
32.51 0.56
0.35GC 963 0.13 0.03 62.46 0.18 33.12 0.39
CC 600 0.12 0.04 62.35 0.23 33.24 0.51
rs2179706  
(IVS 8 + 202T/C)
TT 525 0.09 0.04
0.63
62.39 0.24
0.69
32.96 0.54
0.94TC 1,022 0.15 0.03 62.51 0.17 33.15 0.39
CC 503 0.06 0.04 62.25 0.25 32.89 0.55
rs1042531 
(3′UTR)
TT 866 0.11 0.03
0.92
62.37 0.19
0.89
32.91 0.42
0.55TG 956 0.11 0.03 62.47 0.18 33.03 0.39
GG 227 0.10 0.06 62.34 0.37 33.53 0.83
rs28359554 
(3′UTR)
TT 1,776 0.11 0.02
0.87
62.39 0.13
0.75
33.11 0.29
0.47TC 265 0.12 0.06 62.58 0.34 32.69 0.75
CC 9 −0.18 0.32 61.6 1.82 30.25 3.81
WC, waist circumference.
aAdjusted for age, age-group, gender, maturity, and country. bAdjusted for age, age-group, gender, maturity, country, and height.
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However, although animal studies convincingly illustrated 
that the Pck1 gene modulates obesity and PA, it could be 
that there is, indeed, no effect in humans, either because the 
gene is not necessary for the regulation of these phenotypes 
or because functional variation is absent. Another reason 
could be that the genetic variations within the PCK1 gene 
were not captured completely. Although we had chosen the 
tag-SNPs capturing most of the common genetic variations 
within the PCK1 gene based on the International HapMap 
release 19/phase II (October 2005, on NCBI B34 assembly), 
we captured only 50% of the common variants (MAF >5%) 
according to the most recent release (release 26 phase II and 
III, November 2008, on NCBI B36 assembly, dbSNP b126). 
As such, we cannot exclude that the absence of association in 
our study is due to incomplete coverage of the genetic vari-
ation in PCK1. Finally, the accelerometer variable that was 
used in the present study may be subject to some random 
measurement error and therefore likely to affect the precision 
of the effect estimate in the analysis with PA as outcome (35). 
In recent genome-wide association studies for obesity-re-
lated traits, none of the PCK1 SNPs reached genome-wide 
 significance for association with BMI (36,37), WC (38,39), 
and risk of obesity (40).
In conclusion, the data of the present study suggest that the 
SNPs in the PCK1 gene are not associated with obesity-related 
traits, PA, and fitness in Danish and Estonian 10- and 15-year-
old children. Furthermore, replication of our finding prefer-
ably in an independent larger pediatric cohort with adequate 
statistical power should be performed in the future to confirm 
or refute our findings.
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table 3 results for association tests between PCK1 polymorphisms and physical activity and fitness
Polymorphisms Genotypes
N (physical 
activity 
and 
MVPAa)
N 
(physical 
fitness)
Physical activity  
(counts/min) MVPAa (%)
Physical fitness  
(absolute watts)
Mean s.e. P valueb Mean s.e. P valueb Mean s.e. P valuec
rs1328756 
(−1096T/C)
CC 228 348 615.11 13.36
0.68
8.7 0.3
0.58
151.60 1.51
0.28CT 636 1,014 616.79 7.97 8.6 0.2 152.85 0.88
TT 423 659 609.72 9.79 8.5 0.2 153.65 1.09
rs6070157 
(Ile94Ile)
TT 74 117 605.81 23.41
0.63
8.4 0.5
0.77
149.91 2.59
0.76TC 501 794 620.82 8.98 8.7 0.2 153.42 0.99
CC 712 1,109 610.36 7.53 8.5 0.2 152.74 0.84
rs707555 
(Leu184Val)
GG 966 1,518 619.17 6.45
0.07
8.7 0.1
0.17
153.02 0.72
0.78GC 294 463 600.62 11.69 8.3 0.2 152.01 1.30
CC 25 38 564.32 40.21 7.9 0.8 160.86 4.54
rs2070755  
(IVS 4 + 85C/G)
GG 304 473 617.46 11.55
0.65
8.7 0.2
0.52
152.27 1.29
0.82GC 607 951 614.89 8.16 8.6 0.2 153.87 0.91
CC 372 592 610.43 10.45 8.5 0.2 152.07 1.15
rs2179706  
(IVS 8 + 202T/C)
TT 336 517 616.98 10.98
0.33
8.6 0.2
0.37
152.23 1.23
0.86TC 635 1,012 619.15 7.97 8.7 0.2 153.43 0.88
CC 316 492 601.17 11.31 8.3 0.2 152.50 1.26
rs1042531 
(3’UTR)
TT 549 850 606.19 8.58
0.57
8.5 0.2
0.92
152.52 0.96
0.83TG 603 946 624.24 8.18 8.8 0.2 153.62 0.91
GG 135 224 601.65 17.29 8.3 0.4 150.81 1.87
rs28359554 
(3’UTR)
TT 1,121 1,750 613.35 5.98
0.87
8.6 0.1
0.88
152.90 0.67
0.86TC 160 263 628.34 15.86 8.9 0.3 153.12 1.73
CC 6 8 390.35 81.81 4.7 1.7 144.18 9.91
MVPA, moderate-to-vigorous intensity physical activity.
aTime fraction spent at moderate- and vigorous-intensity physical activity. bAdjusted for age, age-group, gender, maturity, and country. cAdjusted for age, age-group, 
gender, maturity, country, and body weight.
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